PBPIA
BIOA

Pivotal bioVenture Partners Investment Advisor’s BioAge Labs BIOA Stock Holding History

Pivotal bioVenture Partners Investment Advisor’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.4M Hold
653,374
– – 4.08% 9
2025
Q4 		$8.64M Hold
653,374
– – 3.34% 9
2025
Q3 		$3.84M Hold
653,374
– – 2.22% 7
2025
Q2 		$2.7M Hold
653,374
– – 1.67% 9
2025
Q1 		$2.46M Hold
653,374
– – 1.99% 7
2024
Q4 		$3.78M Buy
653,374
+125,727
+24% +$2.17M 2.56% 7
2024
Q3 		$11M Buy
+527,647
New +$10.6M 6.51% 6

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Pivotal bioVenture Partners Investment Advisor's BIOA Position: Q1 2026 in Review

Pivotal bioVenture Partners Investment Advisor held its BioAge Labs (BIOA) position steady in Q1 2026 at 653,374 shares worth $11.4M. The position accounts for 4.08% of the portfolio, ranked #9.

Pivotal bioVenture Partners Investment Advisor first reported a position in BIOA in Q3 2024 and has held it in 7 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Pivotal bioVenture Partners Investment Advisor held 653,374 shares of BioAge Labs worth $11.4M as of Q1 2026.
  • Pivotal bioVenture Partners Investment Advisor left its BioAge Labs share count unchanged in Q1 2026.
  • BioAge Labs made up 4.08% of Pivotal bioVenture Partners Investment Advisor's portfolio in Q1 2026, its #9 holding.
  • Pivotal bioVenture Partners Investment Advisor first reported a position in BioAge Labs in Q3 2024 and has held it in 7 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Pivotal bioVenture Partners Investment Advisor's 13F filing for Q1 2026, filed 14 May 2026.